Interactions of the SV40 Small t Antigen and PP2A in Human Cell Transformation

SV40 Small t 抗原和 PP2A 在人类细胞转化中的相互作用

基本信息

  • 批准号:
    8233031
  • 负责人:
  • 金额:
    $ 32.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

The study of DNA tumor viruses that transform rodent and human cells has led to a greater understanding of the molecular events that program the malignant state. In particular, investigation of the viral oncoproteins specified by the Simian Virus 40 Early Region (SV40 ER) has revealed host cell pathways, whose perturbation play an essential role in the transformation of mammalian cells. Over the last several years, we have focused on the role of the SV40 small t antigen (SV40ST) in human cell transformation. During the last funding period, we have confirmed that the interaction between SV40ST and PP2A contributes directly to human cell transformation. In addition, we have found that the perturbation of PP2A by SV40ST transforms human cells in a manner similar to that induced by cancer-associated mutations of PP2A subunits. These observations identify PP2A as a tumor suppressor in human cancers and suggest that a deeper understanding of the mechanisms by which SV40ST perturbs PP2A function will provide additional insights into tumor initiation and maintenance. In order to understand further the role(s) of PP2A in cell transformation, we propose to combine genetic, biochemical and cell biological approaches to characterize the PP2A complexes involved in cell transformation, to identify the role(s) of RalA in cancer development and to elucidate the molecular pathways perturbed by SV40ST and PP2A in human cell transformation. Investigating the regulation and function of PP2A in cancer development will not only enhance our mechanistic understanding of this tumor suppressor family but will also provide new insights into the pathways that help program the malignant state. In addition, these studies will provide a foundation for strategies to target these pathways therapeutically.
对转化啮齿动物和人类细胞的DNA肿瘤病毒的研究使我们对

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William C. Hahn其他文献

SV40 small T antigen and PP2A phosphatase in cell transformation
  • DOI:
    10.1007/s10555-008-9116-0
  • 发表时间:
    2008-01-23
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Anna A. Sablina;William C. Hahn
  • 通讯作者:
    William C. Hahn
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
人类癌症中与扩增相关的敏感性增益基因纲要
  • DOI:
    10.1038/s41467-025-56301-2
  • 发表时间:
    2025-01-27
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Veronica Rendo;Michael Schubert;Nicholas Khuu;Maria F. Suarez Peredo Rodriguez;Declan Whyte;Xiao Ling;Anouk van den Brink;Kaimeng Huang;Michelle Swift;Yizhou He;Johanna Zerbib;Ross Smith;Jonne Raaijmakers;Pratiti Bandopadhayay;Lillian M. Guenther;Justin H. Hwang;Amanda Iniguez;Susan Moody;Ji-Heui Seo;Elizabeth H. Stover;Levi Garraway;William C. Hahn;Kimberly Stegmaier;René H. Medema;Dipanjan Chowdhury;Maria Colomé-Tatché;Uri Ben-David;Rameen Beroukhim;Floris Foijer
  • 通讯作者:
    Floris Foijer
The present and future of the Cancer Dependency Map
癌症依赖图谱的现在与未来
  • DOI:
    10.1038/s41568-024-00763-x
  • 发表时间:
    2024-10-28
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Rand Arafeh;Tsukasa Shibue;Joshua M. Dempster;William C. Hahn;Francisca Vazquez
  • 通讯作者:
    Francisca Vazquez
Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biol
开发经过认证的中药 (TCM) 植物库,用于系统生物分析
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David Eisenberg;Eric S. J. Harris;Bruce A. Littlefield;Shugeng Cao;Jane A. Craycroft;Robert Scholten;Peter E. Bayliss;Yanling Fu;Wenquan Wang;Yan;Zhongzhen Zhao;Hubiao Chen;Yong Liu;Ted J. Kaptchuk;William C. Hahn;Xiaoxin Wang;Thomas M. Roberts;C. Shamu;Jon Clardy
  • 通讯作者:
    Jon Clardy
Modelling the molecular circuitry of cancer
对癌症的分子电路进行建模
  • DOI:
    10.1038/nrc795
  • 发表时间:
    2002-05-01
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    William C. Hahn;Robert A. Weinberg
  • 通讯作者:
    Robert A. Weinberg

William C. Hahn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William C. Hahn', 18)}}的其他基金

Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
  • 批准号:
    10627744
  • 财政年份:
    2022
  • 资助金额:
    $ 32.8万
  • 项目类别:
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
VRK2甲基化多形性胶质母细胞瘤的新遗传依赖性
  • 批准号:
    10046375
  • 财政年份:
    2020
  • 资助金额:
    $ 32.8万
  • 项目类别:
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
开发和实施多重方法来了解源自患者的癌症模型的生物学和异质性
  • 批准号:
    10004385
  • 财政年份:
    2020
  • 资助金额:
    $ 32.8万
  • 项目类别:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
系统研究患者来源标本中的胰腺癌微环境
  • 批准号:
    10250566
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
PROJECT 4: Interrogating PP2A Signaling in Human Cancers
项目 4:探究人类癌症中的 PP2A 信号传导
  • 批准号:
    9981674
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
系统研究患者来源标本中的胰腺癌微环境
  • 批准号:
    10242454
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
Systematic identification of oncogenic KRAS synthetic lethal interactions
系统鉴定致癌 KRAS 合成致死相互作用
  • 批准号:
    9330127
  • 财政年份:
    2015
  • 资助金额:
    $ 32.8万
  • 项目类别:
Systematic identification of oncogenic KRAS synthetic lethal interactions
系统鉴定致癌 KRAS 合成致死相互作用
  • 批准号:
    9150537
  • 财政年份:
    2015
  • 资助金额:
    $ 32.8万
  • 项目类别:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
丹娜—法伯癌症研究所癌症靶标发现和开发中心
  • 批准号:
    9362809
  • 财政年份:
    2013
  • 资助金额:
    $ 32.8万
  • 项目类别:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
丹娜—法伯癌症研究所癌症靶标发现和开发中心
  • 批准号:
    9979771
  • 财政年份:
    2013
  • 资助金额:
    $ 32.8万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Project 2: Discovery of novel C. difficile antigens using genetic and biochemical approaches
项目2:利用遗传和生化方法发现新的艰难梭菌抗原
  • 批准号:
    10625693
  • 财政年份:
    2023
  • 资助金额:
    $ 32.8万
  • 项目类别:
Genetic and Biochemical Studies on H, Se, and X genes encoded fucosyltransferases responsible for biosynthesis of blood group antigens.
对编码负责血型抗原生物合成的岩藻糖基转移酶的 H、Se 和 X 基因进行遗传和生化研究。
  • 批准号:
    62570261
  • 财政年份:
    1987
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
LEISHMANIA ANTIGENS-BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原-生化和免疫学研究
  • 批准号:
    3134806
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS--BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原——生物化学和免疫学研究
  • 批准号:
    2062053
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS-BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原-生化和免疫学研究
  • 批准号:
    3134809
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS--BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原——生物化学和免疫学研究
  • 批准号:
    2062052
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS--BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原——生物化学和免疫学研究
  • 批准号:
    2062054
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS--BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原——生物化学和免疫学研究
  • 批准号:
    2607754
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS--BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原——生物化学和免疫学研究
  • 批准号:
    2003363
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
LEISHMANIA ANTIGENS-BIOCHEMICAL AND IMMUNOLOGIC STUDIES
利什曼原虫抗原-生化和免疫学研究
  • 批准号:
    3134804
  • 财政年份:
    1985
  • 资助金额:
    $ 32.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了